Cite
HARVARD Citation
Zanker, D. et al. (2020). Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer. Clinical & translational immunology. 9 (9), p. n/a. [Online].